Skip to content
Biodatica
Start free

Investigator

Rushika Miriam Perera

GORDON RESEARCH CONFERENCES · funded by NCI

Companies
1

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$2.1M

Summed across those awards.

First award
Apr 1, 2021

Latest Mar 10, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R13

    2026 Autophagy in Stress, Development and Disease Gordon Research Conference and Gordon Research Seminar

    $4k

    Mar 10, 2026NCIGORDON RESEARCH CONFERENCESNIH RePORTER · 11320325 (opens the source filing in a new tab)

  2. R01

    Identifying and disabling new pathways for macromolecular recycling in pancreatic cancer

    $667k

    Apr 1, 2025NCIUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11129546 (opens the source filing in a new tab)

  3. R01

    Identifying and disabling new pathways for macromolecular recycling in pancreatic cancer

    $664k

    Apr 1, 2025NCIUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11308363 (opens the source filing in a new tab)

  4. R01

    Dissecting new mechanisms of lysosome quality control in health and disease

    $369k

    Apr 1, 2021NCIUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11041055 (opens the source filing in a new tab)

  5. R01

    Targeting the autophagy-lysosome system to block pancreatic cancer

    $372k

    Apr 1, 2021NCIUNIVERSITY OF CALIFORNIA, SAN FRANCISCONIH RePORTER · 11041018 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources